Posted 3/29/2019 11:18 PM (GMT 0)
Humira is 70% likely to get you out of a moderate to severe flare (and does so quicker than Entyvio). However, it is only ~30% likely to maintain a lasting remission that is longer than someone not on a long term remission maintaining drug.
Entyvio has about a 40-50% chance of maintaining a lasting remission (greater than someone not on a longterm remission maintaining drug) but was less likely than Humira to actually get you out of a moderate to severe flair. I don't remember the percentage but I think it was a bit under half chance.
I think that those are both pretty bad odds, but I'd personally rather be on Entyvio during a remission and save Humira for a flare.
***I got my numbers from uptodate. I know I should cite sources but that would take a while to do. So make of this what you will. (this is not medical advice, just database statistics and a personal opinion)